274 related articles for article (PubMed ID: 18394553)
1. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells.
Kirstetter P; Schuster MB; Bereshchenko O; Moore S; Dvinge H; Kurz E; Theilgaard-Mönch K; Månsson R; Pedersen TA; Pabst T; Schrock E; Porse BT; Jacobsen SE; Bertone P; Tenen DG; Nerlov C
Cancer Cell; 2008 Apr; 13(4):299-310. PubMed ID: 18394553
[TBL] [Abstract][Full Text] [Related]
2. C/EBPalpha in leukemogenesis: a matter of being in the right place with the right signals.
Castilla LH
Cancer Cell; 2008 Apr; 13(4):289-91. PubMed ID: 18394549
[TBL] [Abstract][Full Text] [Related]
3. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract][Full Text] [Related]
4. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
[TBL] [Abstract][Full Text] [Related]
5. CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.
Koschmieder S; D'Alò F; Radomska H; Schöneich C; Chang JS; Konopleva M; Kobayashi S; Levantini E; Suh N; Di Ruscio A; Voso MT; Watt JC; Santhanam R; Sargin B; Kantarjian H; Andreeff M; Sporn MB; Perrotti D; Berdel WE; Müller-Tidow C; Serve H; Tenen DG
Blood; 2007 Nov; 110(10):3695-705. PubMed ID: 17671235
[TBL] [Abstract][Full Text] [Related]
6. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
[TBL] [Abstract][Full Text] [Related]
7. Lack of the p42 form of C/EBPα leads to spontaneous immortalization and lineage infidelity of committed myeloid progenitors.
Schuster MB; Frank AK; Bagger FO; Rapin N; Vikesaa J; Porse BT
Exp Hematol; 2013 Oct; 41(10):882-893.e16. PubMed ID: 23831605
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
Katzerke C; Madan V; Gerloff D; Bräuer-Hartmann D; Hartmann JU; Wurm AA; Müller-Tidow C; Schnittger S; Tenen DG; Niederwieser D; Behre G
Blood; 2013 Oct; 122(14):2433-42. PubMed ID: 23974200
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.
Grebien F; Vedadi M; Getlik M; Giambruno R; Grover A; Avellino R; Skucha A; Vittori S; Kuznetsova E; Smil D; Barsyte-Lovejoy D; Li F; Poda G; Schapira M; Wu H; Dong A; Senisterra G; Stukalov A; Huber KVM; Schönegger A; Marcellus R; Bilban M; Bock C; Brown PJ; Zuber J; Bennett KL; Al-Awar R; Delwel R; Nerlov C; Arrowsmith CH; Superti-Furga G
Nat Chem Biol; 2015 Aug; 11(8):571-578. PubMed ID: 26167872
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.
Bereshchenko O; Mancini E; Moore S; Bilbao D; Månsson R; Luc S; Grover A; Jacobsen SE; Bryder D; Nerlov C
Cancer Cell; 2009 Nov; 16(5):390-400. PubMed ID: 19878871
[TBL] [Abstract][Full Text] [Related]
11. Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.
Odaira K; Yasuda T; Okada K; Shimooka T; Kojima Y; Noura M; Tamura S; Kurahashi S; Iwamoto E; Sanada M; Matsumura I; Miyazaki Y; Kojima T; Kiyoi H; Tsuzuki S; Hayakawa F
Cancer Sci; 2023 Mar; 114(3):781-792. PubMed ID: 36341510
[TBL] [Abstract][Full Text] [Related]
12. An evolutionarily conserved PTEN-C/EBPalpha-CTNNA1 axis controls myeloid development and transformation.
Fu CT; Zhu KY; Mi JQ; Liu YF; Murray ST; Fu YF; Ren CG; Dong ZW; Liu YJ; Dong M; Jin Y; Chen Y; Deng M; Zhang W; Chen B; Breslin P; Chen SJ; Chen Z; Becker MW; Zhu J; Zhang JW; Liu TX
Blood; 2010 Jun; 115(23):4715-24. PubMed ID: 20371743
[TBL] [Abstract][Full Text] [Related]
13. CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.
Schmidt L; Heyes E; Scheiblecker L; Eder T; Volpe G; Frampton J; Nerlov C; Valent P; Grembecka J; Grebien F
Leukemia; 2019 Jul; 33(7):1608-1619. PubMed ID: 30679799
[TBL] [Abstract][Full Text] [Related]
14. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms underlying deregulation of C/EBPalpha in acute myeloid leukemia.
Reckzeh K; Cammenga J
Int J Hematol; 2010 May; 91(4):557-68. PubMed ID: 20422469
[TBL] [Abstract][Full Text] [Related]
16. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.
Guibal FC; Alberich-Jorda M; Hirai H; Ebralidze A; Levantini E; Di Ruscio A; Zhang P; Santana-Lemos BA; Neuberg D; Wagers AJ; Rego EM; Tenen DG
Blood; 2009 Dec; 114(27):5415-25. PubMed ID: 19797526
[TBL] [Abstract][Full Text] [Related]
17. A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse.
Schwieger M; Löhler J; Fischer M; Herwig U; Tenen DG; Stocking C
Blood; 2004 Apr; 103(7):2744-52. PubMed ID: 14656889
[TBL] [Abstract][Full Text] [Related]
18. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice.
Lange AP; Almeida LY; Araújo Silva CL; Scheucher PS; Chahud F; Krause A; Bohlander SK; Rego EM
Braz J Med Biol Res; 2019; 52(6):e8424. PubMed ID: 31141090
[TBL] [Abstract][Full Text] [Related]
20. EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
Zjablovskaja P; Kardosova M; Danek P; Angelisova P; Benoukraf T; Wurm AA; Kalina T; Sian S; Balastik M; Delwel R; Brdicka T; Tenen DG; Behre G; Fiore F; Malissen B; Horejsi V; Alberich-Jorda M
Cell Death Differ; 2017 Apr; 24(4):705-716. PubMed ID: 28186500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
